Breaking News Headlines Today

News from Pharmaphorum

See all of Pharmaphorum news coverage in one place. Discover how Pharmaphorum’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve aggregated 423 of Pharmaphorum’s headlines and news stories over the past 3 months.

The Ground News media bias check for Pharmaphorum is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if Pharmaphorum is credible or reliable, look no further. We rank Pharmaphorum as High factuality. Find out more about our methodology here.

Information about Pharmaphorum

Where is Pharmaphorum located?Pharmaphorum's Website

Media Bias Ratings

Average Bias Rating:

Center

byAd Fontes Media

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

European Commission Approved DARZALEX Faspro® for Adult Patients with Smouldering Multiple Myeloma

100% Center coverage: 3 sources

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Janssen-Cilag International NV, a Johnson & Johnson company,...NHS · Belgium See the Story

News from Pharmaphorum

News from Pharmaphorum

Information about Pharmaphorum

Media Bias Ratings

Factuality

Ownership

Top Pharmaphorum News

AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh

FDA Names Former Pharmaceutical Company Executive to Oversee US Drug Program

US bans vaccine ingredient targeted by anti-vaxxers

France's Sanofi to acquire biotech firm Vicebio for $1.15 billion

Sarepta Backs Down and Pauses Elevidys Shipments

Pharma go-to-market transformation: Why cross-functional silos cost billions

AZ boasts phase 3 win for self-administered gMG drug

mRNA ‘wake-up call’ shows promise as universal cancer vaccine

GSK Adds EU to Blenrep Checklist as FDA Sets New PDUFA Date

AI health tech Respiree closes $11.6m Series A

European Commission Approved DARZALEX Faspro® for Adult Patients with Smouldering Multiple Myeloma

Similar News Topics

Topics Most Covered by Pharmaphorum

Sources Covering Similar Topics

Breaking News Topics Related to Pharmaphorum

Information about Pharmaphorum

Media Bias Ratings

Factuality

Ownership

France's Sanofi to acquire biotech firm Vicebio for $1.15 billion

Sarepta Backs Down and Pauses Elevidys Shipments

Pharma go-to-market transformation: Why cross-functional silos cost billions

AZ boasts phase 3 win for self-administered gMG drug

mRNA ‘wake-up call’ shows promise as universal cancer vaccine

GSK Adds EU to Blenrep Checklist as FDA Sets New PDUFA Date

AI health tech Respiree closes $11.6m Series A

European Commission Approved DARZALEX Faspro® for Adult Patients with Smouldering Multiple Myeloma